US Patent Issued to Seyltx on Sept. 8 for "Compositions and methods for treating idiopathic pulmonary fibrosis" (California Inventor)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,728,121, issued on Sept. 8, was assigned to Seyltx Inc. (Pittsburgh).

"Compositions and methods for treating idiopathic pulmonary fibrosis" was invented by Mark Williams (Winnipeg, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The use of pharmaceutically active compounds for treating chronic lung diseases including idiopathic pulmonary fibrosis is disclosed. The compounds include NMDA receptor antagonists, glutamate 2b receptor antagonists and sigma receptor agonists. In particular, the use of bromantane, ifenprodil, radiprodil, bemithyl and repirinast are effective in treating idiopathic pulmonary fibrosis. Methods of use thereof are also discl...